1. Reconciling Cancer Care Costs Reported by Different Government Agencies in Taiwan: Why Costing Approach Matters? 
Chun-Ru Chien, MD, PhD, Ya-Chen Tina Shih, PhD 
Value in Health Regional Issues 
Volume 1, Issue 1, Pages (May 2012)
DOI: /j.vhri
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Selection of study population and definitions used in costing approaches.
Value in Health Regional Issues 2012 1, DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

3. Fig. 2
Comparisons of total costs of cancer by costing method. BNHI, Bureau of National Health Insurance; DOH, Department of Health; NHRI, National Health Research Institute; RVU, relative value unit.
Value in Health Regional Issues 2012 1, DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

4. Fig. 3
Comparison of cancer cases by costing method. BNHI, Bureau of National Health Insurance; DOH, Department of Health; NHRI, National Health Research Institute.
Value in Health Regional Issues 2012 1, DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

5. Fig. 4
Comparison of mean cost per patient, by costing method. BNHI, Bureau of National Health Insurance; DOH, Department of Health; NHRI, National Health Research Institute; RVU, relative value unit.
Value in Health Regional Issues 2012 1, DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions